Reacción a "Administering immunotherapy and chemotherapy in the morning could improve their effectiveness against lung cancer"

These results are surprising and difficult to understand, given that the half-life of the agents is weeks, and yet the time of administration radically influences the results. I am very pleased that our infusions in my unit are almost always in the morning. These results provide sufficient evidence for this to become routine from now on.